TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells

Cellular Signalling

Volumn 26, Issue 2, 2014, Pages 240-252

  Sengupta, Suman ^a,b   Jana, Samir ^a   Bhattacharyya, Arindam ^a  

^a UNIVERSITY OF CALCUTTA   (India)

^b UNIVERSITY OF KALYANI   (India)

Author keywords

CDC 25A; Cell proliferation; NFAT; Smad2; TGF

Indexed keywords

CDC 25A PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; PHOSPHATASE; SMAD2 PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BREAST METASTASIS; CANCER CELL; CANCER GROWTH; CELL CYCLE REGULATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; UPREGULATION;

CDC 25A; CELL PROLIFERATION; EMT; EPITHELIAL TO MESENCHYMAL TRANSITION; NFAT; NUCLEAR FACTOR OF ACTIVATED T-CELLS; SMAD2; TGF-Β; TRANSFORMING GROWTH FACTOR-Β;

APOPTOSIS; BREAST NEOPLASMS; CADHERINS; CDC25 PHOSPHATASES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; NFATC TRANSCRIPTION FACTORS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84889031043     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2013.11.013     Document Type: Article

References (45)

1. Bendre M., Gaddy D., Nicholas R.W., Suva L.J. Clin. Orthop. Relat. Res. 2003, 415:S39-S45.
2. Coleman R.E. Clin. Cancer Res. 2006, 12:6243s-6249s.
3. Oliveira M.J., Van Damme J., Lauwaet T., et al. EMBO J. 2003, 22(22):6161-6173.
4. Leask A., Abraham D.J. FASEB J. 2004, 18(7):816-827.
5. Kang Y., He W., Tulley S., et al. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(39):13909-13914.
6. Haviv I., Polyak K., Qiu W., Hu M. Cell Cycle 2009, 8(4):589-595.
7. Derynck Rik, Zhang Ying E. Nature 2003, 425.
8. Brown Kimberly A., Ham Amy-Joan L., et al. J. Cell. Biochem. 2008, 105(2):596-611.
9. Singh Garima, Singh Shiv K., König Alexander, et al. J. Biol. Chem. 2010, 285:27241-27250.
10. Luo C., Shaw K.T., Raghavan A., et al. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:8907-8989.
11. Shibasaki F., Price E.R., Milan D., McKeon F. Nature 1996, 382:370-373.
12. Macian F. Nat. Rev. Immunol. 2005, 5:472-484.
13. Koepp D.M., Harper J.W., Elledge S.J. Cell 1999, 97:431-434.
14. Baldin V., Cans C., Superti-Furga G., Ducommun B. Oncogene 1997, 14:2485-2495.
15. Sasaki H., Yukiue H., Kobayashi Y., Tanahashi M., et al. Cancer Lett. 2001, 173:187-192.
16. Cangi M.G., Cukor B., Soung P., et al. J. Clin. Invest. 2000, 106:753-761.
17. Takemasa I., Yamamoto H., Sekimoto M., et al. Cancer Res. 2000, 60:3043-3050.
18. Sengupta S., Jana S., Biswas S., Mandal P., Bhattacharyya A. Clin. Exp. Metastasis 2013, 10.1007/s10585-013-9600-y.
19. Hernandez S., Bessa X., Bea S., et al. Lab. Invest. 2001, 81:465-473.
20. Bureik M., Rief N., Drescher R., et al. Int. J. Oncol. 2000, 17:1251-1258.
21. Liu Fang, Hata Akiko, Baker Julie C., et al. Nature 1996, 38:620-623.
22. Massagué Joan, Seoane Joan Genes Dev. 2005, 19:2783-2810.
23. Talmadge J.E. Cancer Res. 2007, 67:11471-11475.
24. Beals Chan R., Neil A. Genes Dev. 1997, 11:824-834.
25. Viola J.P., Carvalho L.D., Fonseca B.P. Braz. J. Med. Biol. Res. 2005, 38(3):335-344.
26. Weigelt B., Peterse J.L., van't Veer L.J. Nat. Rev. Cancer 2005, 5:591-602.
27. Shook D., Keller R. Mech. Dev. 2003, 120(11):1351-1383.
28. Choi S.S., Diehl A.M. Hepatology 2009, 50(6):2007-2013.
29. Tucker R.P. Int. J. Biochem. Cell Biol. 2004, 36(2):173-177.
30. Blomberg I., Hoffmann I. Mol. Cell. Biol. 1999, 19:6183-6194.
31. Molinari M., Mercurio C., Dominguez J., et al. EMBO Rep. 2000, 1:71-79.
32. Wu Weiguo, Fan You-Hong, Kemp Bonnie L., et al. Cancer Res. 1998, 58:4082-4085.
33. Kudo Y., Yasui W., Ue T., et al. Jpn. J. Cancer Res. 1997, (88):947-952.
34. Cangi M.G., Cukor B., Soung P., et al. J. Clin. Invest. 2000, (106):753-761.
35. Turowski P., Franckhauser C., Morris M.C., et al. Mol. Biol. Cell 2003, 14:2984-2998.
36. Caetano M.S., Vieira-de-Abreu A., Teixeira L.K., et al. FASEB J. 2002, 16:1940-1942.
37. Masuda Esteban S., Liu Jie, Ryuimamura, Imai Shin-Chiro, et al. Mol. Cell. Biol. 1995, 15:2697-2706.
38. Crabtree G.R., Olson E.N. Cell 2002, 109:S-67-S-79. (Suppl.).
39. Baksh S., DeCaprio J.A., Burakoff S.J. Oncogene 2000, 19:2820-2827.
40. Iniguez Miguel A., Martinez-Martinez Sara, Punzon Carmen, et al. J. Biol. Chem. 2000, 275:23627-23635.
41. de Caestecker Mark P., Piek Ester, Roberts Anita B. J. Natl. Cancer Inst. 2000, 92(17).
42. Mullen Alan C., Orlando David A., Newman Jamie J., et al. Cell 2001, 147:565-576.
43. Dennler S., Itoh S., Vivien D., et al. EMBO J. 1998, 17:3091-3100.
44. Shi Y., Wang Y.F., Jayaraman L., Yang H., Massagué J., Pavletich N.P. Cell 1998, 94:585-594.
45. Zawel L., Dai J.L., Buckhaults P., Zhou S., Kinzler K.W., Vogelstein B., Kern S.E. Mol. Cell 1998, 1:611-617.